Log In
BCIQ
Print this Print this
 

LIPO-102

  Manage Alerts
Collapse Summary General Information
Company Neothetics Inc.
DescriptionInjectable aqueous combination of salmeterol and fluticasone propionate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today